Overview

This trial is active, not recruiting.

Condition body fat disorder
Treatment the zeltiq system
Sponsor Zeltiq Aesthetics
Start date September 2015
End date February 2016
Trial size 45 participants
Trial identifier NCT02554760, ZA15-004

Summary

Evaluate the safety and efficacy of non-invasive subcutaneous fat layer reduction in the flank using an applicator with the Crown Cooling Insert.

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Endpoint classification safety/efficacy study
Intervention model single group assignment
Masking open label
Arm
(Experimental)
The treatments are designed to see if the fat, on the flanks, can be reduced.
the zeltiq system
The CoolSculpting machine will be used to perform the treatments.

Primary Outcomes

Measure
Effectiveness endpoint
time frame: 12 weeks post treatment

Eligibility Criteria

Male or female participants from 22 years up to 65 years old.

Inclusion Criteria: - Male or female subjects > 22 years of age and < 65 years of age. - Subject has clearly visible fat on the flanks, which in the investigator's opinion, may benefit from the treatment. - No weight change exceeding 5% of body weight in the preceding month. - Subject with body mass index (BMI) up to 30. BMI is defined as weight in pounds multiplied by 703 divided by the square of the height in inches. - Subject agrees to maintain his/her weight (i.e., within 5%) by not making any major changes in their diet or exercise routine during the course of the study. - Subject has read and signed the study written informed consent form. Exclusion Criteria - Subject has had a surgical procedure(s) in the area of intended treatment. - Subject has had an invasive fat reduction procedure (e.g., liposuction, mesotherapy) in the area of intended treatment. - Subject has had a non-invasive fat reduction and/or body contouring procedure in the area of intended treatment within the past 12 months. - Subject needs to administer, or has a known history of subcutaneous injections into the area of intended treatment (e.g., heparin, insulin) within the past month. - Subject has a known history of cryoglobulinemia, cold urticaria, or paroxysmal cold hemoglobinuria. - Subject has a known history of Raynaud's disease, or any known condition with a response to cold exposure that limits blood flow to the skin. - Subject has a history of bleeding disorder or is taking any medication that in the investigator's opinion may increase the subject's risk of bruising. - Subject is taking or has taken diet pills or supplements within the past month. - Subject has any dermatological conditions, such as moderate to excessive skin laxity, or scars in the location of the treatment sites that may interfere with the treatment or evaluation (stretch marks is not an exclusion). - Subject has an active implanted device such as a pacemaker, defibrillator, or drug delivery system - Subject is pregnant or intending to become pregnant during the study period (in the next 5 months). - Subject is lactating or has been lactating in the past 6 months. - Subject has a history of hernia in the areas to be treated. - Subject is unable or unwilling to comply with the study requirements. - Subject is currently enrolled in a clinical study of any other unapproved investigational drug or device. - Any other condition or laboratory value that would, in the professional opinion of the investigator, potentially affect the subject's response or the integrity of the data or would pose an unacceptable risk to the subject.

Additional Information

Official title CoolSculpting the Flank Using an Applicator With a Crown Cooling Insert
Trial information was received from ClinicalTrials.gov and was last updated in January 2016.
Information provided to ClinicalTrials.gov by Zeltiq Aesthetics.